Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incretin-based therapy in late preclinical type 1 diabetes
2014-004761-25Phase 2Completed
- Sponsor
- Riitta Veijola
- Start
- Dec 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of liraglutide in diabetes mellitus type 1 (T1D), sponsored by Riitta Veijola. Primary endpoints: Insulin secretion, Reversal of dysglycemia and 1 more. Started Dec 2015; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-004761-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004761-25.